Michal Mandelboim to Humans
This is a "connection" page, showing publications Michal Mandelboim has written about Humans.
Connection Strength
0.113
-
Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel. Euro Surveill. 2021 07; 26(26).
Score: 0.008
-
Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2. N Engl J Med. 2021 06 24; 384(25):2453-2454.
Score: 0.008
-
Genomic variation and epidemiology of SARS-CoV-2 importation and early circulation in Israel. PLoS One. 2021; 16(3):e0243265.
Score: 0.007
-
Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells. PLoS One. 2021; 16(2):e0247128.
Score: 0.007
-
UV-LED disinfection of Coronavirus: Wavelength effect. J Photochem Photobiol B. 2020 Nov; 212:112044.
Score: 0.007
-
Comprehensive Analyses of SARS-CoV-2 Transmission in a Public Health Virology Laboratory. Viruses. 2020 08 05; 12(8).
Score: 0.007
-
Human Coronavirus Infections in Israel: Epidemiology, Clinical Symptoms and Summer Seasonality of HCoV-HKU1. Viruses. 2018 09 21; 10(10).
Score: 0.006
-
Exceptional influenza morbidity in summer season of 2017 in Israel may predict the vaccine efficiency in the coming winter. Vaccine. 2018 03 07; 36(11):1326-1329.
Score: 0.006
-
Genetic divergence of Influenza A(H3N2) amino acid substitutions mark the beginning of the 2016-2017 winter season in Israel. J Clin Virol. 2017 08; 93:71-75.
Score: 0.006
-
A(H1N1)pdm09 influenza infection: vaccine inefficiency. Oncotarget. 2017 May 16; 8(20):32856-32863.
Score: 0.006
-
Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study. Acta Ophthalmol. 2017 Dec; 95(8):e686-e692.
Score: 0.006
-
Influenza A(H1N1)pdm 2009 and influenza B virus co-infection in hospitalized and non-hospitalized patients during the 2015-2016 epidemic season in Israel. J Clin Virol. 2017 03; 88:12-16.
Score: 0.006
-
The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variants. Cell Rep. 2021 09 07; 36(10):109679.
Score: 0.002
-
Sensitive Immunodetection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern 501Y.V2 and 501Y.V1. J Infect Dis. 2021 08 16; 224(4):616-619.
Score: 0.002
-
Prolonged detection of complete viral genomes demonstrated by SARS-CoV-2 sequencing of serial respiratory specimens. PLoS One. 2021; 16(8):e0255691.
Score: 0.002
-
The role of mouthwash sampling in SARS-CoV-2 diagnosis. Eur J Clin Microbiol Infect Dis. 2021 Oct; 40(10):2199-2206.
Score: 0.002
-
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. N Engl J Med. 2021 10 14; 385(16):1474-1484.
Score: 0.002
-
BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers. Lancet Respir Med. 2021 09; 9(9):999-1009.
Score: 0.002
-
Human Kidney Spheroids and Monolayers Provide Insights into SARS-CoV-2 Renal Interactions. J Am Soc Nephrol. 2021 09; 32(9):2242-2254.
Score: 0.002
-
BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody response. J Heart Lung Transplant. 2021 08; 40(8):759-762.
Score: 0.002
-
Improved sensitivity, safety, and rapidity of COVID-19 tests by replacing viral storage solution with lysis buffer. PLoS One. 2021; 16(3):e0249149.
Score: 0.002
-
Absence of in-flight transmission of SARS-CoV-2 likely due to use of face masks on board. J Travel Med. 2020 12 23; 27(8).
Score: 0.002
-
Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis. PLoS One. 2020; 15(11):e0241164.
Score: 0.002
-
Characteristics of Clinically Asymptomatic Patients with SARS-CoV-2 Infections, Case Series. Prehosp Disaster Med. 2021 Feb; 36(1):125-128.
Score: 0.002
-
Intensive Care Admissions and Associated Severity of Influenza B Versus A During Influenza B Vaccine-mismatched Seasons. Clin Infect Dis. 2019 08 30; 69(6):1049-1052.
Score: 0.002
-
Characterization of human parainfluenza virus-3 circulating in Israel, 2012-2015. J Clin Virol. 2018 10; 107:19-24.
Score: 0.002
-
Seasonal Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza in Primary Care in Israel, 2016-2017 Season: Insights Into Novel Age-Specific Analysis. Clin Infect Dis. 2018 04 17; 66(9):1383-1391.
Score: 0.002
-
Effectiveness of influenza vaccine in preventing medically-attended influenza virus infection in primary care, Israel, influenza seasons 2014/15 and 2015/16. Euro Surveill. 2018 02; 23(7).
Score: 0.002
-
Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression. Sci Rep. 2017 10 12; 7(1):13090.
Score: 0.001
-
NKp46 Recognizes the Sigma1 Protein of Reovirus: Implications for Reovirus-Based Cancer Therapy. J Virol. 2017 10 01; 91(19).
Score: 0.001
-
NK-cell receptors NKp46 and NCR1 control human metapneumovirus infection. Eur J Immunol. 2017 04; 47(4):692-703.
Score: 0.001